Antithrombotic-Associated Bleeding

OCT 30, 202644 MIN

Description

In this episode, Sam Ashoo, MD, Dr. Christopher Baugh, MD, MBA, and Dr. Xin Qi, MD, discuss the October 2026 Emergency Medicine Practice article, Antithrombotic-Associated Bleeding: Management in the Emergency Department. 1:18 — Guest introductions 1:58 — Why the authors chose this topic 3:11 — Epidemiology 4:27 — Why DOACs over warfarin 5:15 — Bleeding trends 6:55 — Overlapping antithrombotic regimens 8:09 — Reversibility of agents 9:38 — Bedside priorities 11:31 — Bleeding patterns by drug class & three groups 13:50 — Antithrombotics & traumatic bleeding risk 14:26 — Pre-hospital considerations 16:09 — Indications for antithrombotic use & risk of reversing 17:54 — Gray-area decisions 19:02 — Initial resuscitation 20:08 — Blood product ratios 21:24 — PATCH trial 22:04 — TXA evidence 23:36 — GI bleed adjuncts 24:31 — Critical site bleeds 27:20 — Endoscopy timing 30:00 — Reversal agents 32:50 — Idarucizumab for dabigatran 33:54 — Antiplatelet reversal 36:15 — Warfarin reversal 38:36 — Protamine for heparin/LMWH 39:37 — Fibrinolytic reversal 40:14 — Pre-procedural antithrombotic management 42:39 — Emerging labs 43:50 — Wrap-up & closing promo Subscribers, take the CME test here. Emergency Medicine Residents, get your free subscription by writing [email protected]